• Citigroup maintains an "Outperform" rating for Genius Sports Limited (NYSE: GENI), with a stock price of $11.32 and a raised price target from $15 to $17 by Citizens JMP.
• A significant 290% increase in options trading activity, indicating heightened investor interest and potential bullish sentiment towards GENI's future performance.
• Institutional investors, including Hodges Capital Management Inc. and Envestnet Asset Management Inc., have significantly increased their holdings, showcasing confidence in the company's growth prospects.

Genius Sports Limited (NYSE: GENI), a prominent player in the sports data and technology industry, provides data management and integrity services to sports leagues and organizations worldwide. On December 4, 2025, Citigroup maintained its "Outperform" rating for GENI, with the stock priced at $11.32. Citizens JMP also raised its price target from $15 to $17, as highlighted by TheFly.

The stock has seen a notable increase in options trading activity, with traders acquiring 13,190 call options. This is a significant 290% increase compared to the usual volume of 3,380 call options. This surge in options trading indicates heightened investor interest and potential bullish sentiment towards GENI's future performance.

Institutional investors have also been actively adjusting their positions in Genius Sports. Hodges Capital Management Inc. increased its holdings by 351.7%, now owning 971,235 shares valued at over $10 million. Envestnet Asset Management Inc. raised its stake by 194.9% during the first quarter, now holding 48,904 shares worth $490,000. These moves suggest confidence in the company's growth prospects.

GENI's stock price has experienced a significant increase of approximately 11.97%, rising by $1.21. The stock has fluctuated between a low of $10.64 and a high of $11.58 during the day. Over the past year, it has reached a high of $13.73 and a low of $8.15. The company's market capitalization is approximately $2.7 billion, with a trading volume of 17.24 million shares.